Toggle navigation
Home
Search
Services
Blog
Contact
About
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail
Protein Sciences Corporation, Meriden, CT, United States
Search 21 grants from Gail Smith
Search grants from Protein Sciences Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Breast Cancer Cell Dormancy is Orchestrated by Stroma & Tissue Microenvironment
Systems Genetics of the HPA
Brain Plasticity and Local Sleep Homeostasis: An Electrophysiological
Enhanced Resolution in Microdevice Electrophoresis
Resource for Development of Biomedical Mass Spectrometry
Recently added grants:
Targeting follicular helper CD4 T cells in SLE
The HIV Latent Reservoir, Suboptimal Immune Response on Antiretroviral Therapy, and Exogenous Cytokine Therapies
Mechanisms of inv(16) acute myeloid leukemia
Natural killer cell regulation of the germinal center HIV neutralizing antibody response
Engineering Nanomaterials to Prime Immunity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI085333-000
Application #
2711335
Study Section
Project Start
1997-12-19
Project End
Budget Start
1997-12-19
Budget End
1998-04-18
Support Year
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Protein Sciences Corporation
Department
Type
DUNS #
City
Meriden
State
CT
Country
United States
Zip Code
06450
Related projects
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
Comments
Be the first to comment on this grant